Immunexpress
PrivateLast Round
Grant
Jun 16, 2020
Total Funding Raised
$9.42M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Immunexpress is a biotechnology company that develops and commercializes molecular diagnostic technologies designed for the early detection of sepsis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Immunexpress Comparables
Compare Immunexpress with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ASEP Medical Holdings Inc. | 78% | |
| GenomeKey | 74% | |
| Inflammatix | 74% |
Immunexpress Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 16, 2020 | ||||
| VC Round | Oct 3, 2019 | ||||
| Grant | Feb 6, 2019 | ||||
| Series A | Mar 5, 2014 | ||||
| Private Equity | Jun 19, 2012 |
Immunexpress Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 236% MoM, reaching 1.5K.
- Jun 1, 2025
Monthly visitors grew 194% MoM, reaching 2.5K.
Immunexpress Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Immunexpress's valuation, stock price, and market status.
Is Immunexpress a public or private company?
Immunexpress is a private company.
What is the current stock price of Immunexpress?
Immunexpress is a private company with no public stock price. No recent secondary market data is available.
How much is Immunexpress worth (valuation)?
Valuation information for Immunexpress is not publicly available.
Can I buy Immunexpress stock?
Immunexpress shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Immunexpress's last funding round?
Immunexpress's most recent funding round was Grant on June 16, 2020.
Who are the main investors in Immunexpress?
Key investors in Immunexpress include U.S. Department of Health and Human Services, Public Health Emergency Medical Countermeasures Enterprise.
Will Immunexpress IPO soon?
No public IPO plans have been announced for Immunexpress.
How can I track Immunexpress secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Immunexpress's secondary market activity and sign up for updates.